Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study.
Saved in:
| Title: | Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study. |
|---|---|
| Authors: | Al-Roughani R; Division of Neurology, Amiri Hospital, Sharq, Kuwait., Zakaria M; Department of Neurology, Ain Shams University, Cairo, Egypt., Cupler EJ; Division of Neurology, Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Taha K; Neurology and Immunology Medical Affairs, EMEA Region, Merck Serono Middle East FZ-Ltd., Dubai, United Arab Emirates. |
| Source: | Frontiers in neurology [Front Neurol] 2023 Nov 28; Vol. 14, pp. 1257455. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
